Cancer News and Research

Latest Cancer News and Research

Graphic warning labels can motivate smokers to quit

Young adults are more likely to appreciate the dangers of smoking when warnings are presented in images as well as text, according to a new study by a Washington State University Vancouver psychologist.

7 Apr 2015

Many women diagnosed with breast cancer concerned about genetic risk of developing other cancers

A new study from the University of Michigan Comprehensive Cancer Center finds that many women diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer.

7 Apr 2015

MabVax closes $11.6 million in private placement

MabVax Therapeutics Holdings, Inc., a clinical-stage cancer immunotherapy company, is pleased to announce that it has closed on gross proceeds of approximately $11.6 million in a private placement (the "Private Placement") led by OPKO Health, Inc. and Dr. Phillip Frost, CEO and Chairman of OPKO Health.

6 Apr 2015

Regular consumption of nuts reduce mortality by more than 20%

Nuts are a key element of a healthy diet. According to The World Health Organization (WHO), a healthy diet including nuts, regular exercise, the maintenance of ideal weight and staying away from tobacco and alcohol could be sufficient to prevent cancer cases.

6 Apr 2015

Natera raises $55.5 million in funding led by Sofinnova Ventures

Natera, Inc., a leader in non-invasive genetic testing, today announced that it has raised approximately $55.5 million in funding led by Silicon Valley life sciences investment firm Sofinnova Ventures. This financing round also includes participation from Capital Research and Management, Franklin Templeton Investments, Jennison Associates, RA Capital Management, Healthcor Partners and OrbiMed Advisors.

From Natera 6 Apr 2015

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Amgen today announced that the European Commission approved a new use of Vectibix (panitumumab) as first-line treatment in combination with FOLFIRI for the treatment of adult patients with wild-type (WT) RAS metastatic colorectal cancer (mCRC).

6 Apr 2015

Findings of Ariosa's non-invasive prenatal testing study published online in NEJM

Results from the largest clinical trial to date, comparing non-invasive prenatal testing (NIPT) using the Harmony Prenatal Test with conventional first trimester combined screening (FTS) in a general pregnancy population have been published online in The New England Journal of Medicine.

6 Apr 2015

Personalized cancer vaccines can be used to marshal powerful immune response

Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients' tumors, according to early data in a first-in-people clinical trial at Washington University School of Medicine in St. Louis.

6 Apr 2015

Researchers identify 22 genetic variations associated with increased risk of prostate cancer

Prostate cancer affects one out of every 6 men during their lifetime and is the second most common cause of cancer-related death for men in the United States, resulting in an estimated 27,500 deaths in 2015. Identifying those men who have a higher risk of developing prostate cancer may reduce mortality.

6 Apr 2015

CHLA infectious diseases specialist discusses how parents can prevent measles outbreak

Since December, there have been more than 130 confirmed cases of measles in the state of California, most of them connected to an outbreak that originated in a Southern California amusement park. Many of the infected persons were not vaccinated against the extremely contagious virus, which manifests itself through rash, fever and coughing.

6 Apr 2015

Sanford-Burnham, Daiichi Sankyo sign licensing agreement to expand development of small molecule

Sanford-Burnham Medical Research Institute today announced that it has signed a licensing agreement to further develop a first-in-class small molecule with Daiichi Sankyo for the treatment of cardiovascular-metabolic disease.

6 Apr 2015

Symposium to highlight latest thinking related to obesity

The 15th Plymouth Obesity, Diabetes and Metabolic Syndrome Symposium will take place at Plymouth Postgraduate Medical Centre on 21st May.

6 Apr 2015

Researchers analyze false-positive results from new prenatal genetic screens

Prenatal blood screening for extra or missing chromosomes in the fetus might give false-positive results if the mother's genome contains more than the usual number of certain DNA segments.

6 Apr 2015

UC Davis researchers unravel how micro RNA could potentially lead to novel cancer therapies

The micro RNA miR-22 has long been known for its ability to suppress cancer. However, questions remain about how it achieves this feat. For example, which molecules are regulating miR-22, and which are miR22 targets?

6 Apr 2015

Scientists identify small RNA molecule that can suppress cancer-causing genes in GBM

Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor.

6 Apr 2015

Mayo Clinic-led researchers combine genetic variants to improve identification of women with breast cancer

Recent large-scale genomic analyses have uncovered dozens of common genetic variants that are associated with breast cancer. Each variant, however, contributes only a tiny amount to a person's overall risk of developing the disease.

6 Apr 2015

Simple test outperforms current standard test for early-stage prostate cancer

A test that costs less than a $1 and yields results in minutes has been shown in newly published studies to be more sensitive and more exact than the current standard test for early-stage prostate cancer.

6 Apr 2015

Combination of signaling molecules can inhibit growth of breast cancer cells

Researchers at UT Southwestern Medical Center have uncovered how the body's inflammatory response can alter how estrogen promotes the growth of breast cancer cells.

6 Apr 2015

U-M's Taubman Institute receives $3 million gift to support next generation of medical research

A $3 million gift from noted business and philanthropic leaders Leslie and Abigail Wexner will support the next generation of medical research trailblazers at the University of Michigan through grants from the A. Alfred Taubman Medical Research Institute.

6 Apr 2015

Astellas Pharma, MD Anderson sign option agreement to research and develop new treatment for AML

Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML).

6 Apr 2015

Cancer News and Research

Latest Cancer News and Research

Graphic warning labels can motivate smokers to quit

Many women diagnosed with breast cancer concerned about genetic risk of developing other cancers

MabVax closes $11.6 million in private placement

Regular consumption of nuts reduce mortality by more than 20%

Natera raises $55.5 million in funding led by Sofinnova Ventures

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Findings of Ariosa's non-invasive prenatal testing study published online in NEJM

Personalized cancer vaccines can be used to marshal powerful immune response

Researchers identify 22 genetic variations associated with increased risk of prostate cancer

CHLA infectious diseases specialist discusses how parents can prevent measles outbreak

Sanford-Burnham, Daiichi Sankyo sign licensing agreement to expand development of small molecule

Symposium to highlight latest thinking related to obesity

Researchers analyze false-positive results from new prenatal genetic screens

UC Davis researchers unravel how micro RNA could potentially lead to novel cancer therapies

Scientists identify small RNA molecule that can suppress cancer-causing genes in GBM

Mayo Clinic-led researchers combine genetic variants to improve identification of women with breast cancer

Simple test outperforms current standard test for early-stage prostate cancer

Combination of signaling molecules can inhibit growth of breast cancer cells

U-M's Taubman Institute receives $3 million gift to support next generation of medical research

Astellas Pharma, MD Anderson sign option agreement to research and develop new treatment for AML

Industry Focus eBook - Oncology (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in